Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
doi: 10.1172/JCI116186
Current GLP-1 analogues approved for use in the United States and the European Union include: exenatide twice daily [4], exenatide once weekly [5], liraglutide once daily [6], lixisenatide once daily (not approved in the U.S.) [7] and albiglutide once weekly [8], which are all delivered through subcutaneous injection and initial dose titration is required to improve gastrointestinal tolerance
Reconstitute with a suitable sterile solvent
Q: Are GLP-1s addictive or dangerous
US$ 26.78
US$ 20.12
US$ 22.67
